We exist to improve the lives
of everyone affected by epilepsy

Accord and Actavis topiramate UK stock update

24 Jan 2018

Update as of 24 January 2018:

Accord 50mg topiramate tablets are back in stock in the UK.

There is limited stock available of 25mg, 100mg and 200mg Accord topiramate tablets, with more stock expected soon.

Actavis topiramate tablets are out of stock in all doses. Actavis expects to have them back in stock in February

Original story 21 December 2017:

Accord topiramate tablets are out of stock in the UK in all doses.

Accord expects the 25mg, 50mg and 100mg tablets to be back in stock in February. The 200mg tablets may be back in stock in mid-January.

If you usually take Accord topiramate, your pharmacist might give you a different version of topiramate when you next pick up your prescription. If you have any concerns about this, speak to your family doctor, epilepsy nurse or epilepsy specialist.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Use our email helpline service -- your question will be sent directly to our trained helpline advisors who will reply to you. If you post a question about your epilepsy as a comment on a page, it may not be replied to so please use the email helpline service.

Want to talk to other people with epilepsy?

Take a look at forum4e our online community for people with epilepsy. Anyone with epilepsy over the age of 16 can join, from anywhere in the world.

Comment about this page?

We welcome feedback on the content of our website. If you have any comments about the page you were reading, then please complete the form below.

All comments are reviewed by a moderator before appearing on the site. Once the comment appears, your name and comment will be seen by other visitors to the site. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant. Comments may also be edited or deleted if they are not relevant to the page on which they are entered.

By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.